Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 4/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | POLA1 | P09884 | 1/20 | 0.41 |
| ▸ | POLD1 | P28340 | 1/20 | 0.41 |
| ▸ | TK1 | P04183 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28570790 | 0.98 | TYMP (0.44) | TYMPPOLBPOLA1POLD1TK1 | |
| SCHEMBL3364511 | 0.97 | POLB (0.44) | TYMPPOLBPOLA1POLD1TK1 | |
| SCHEMBL1452492 | 0.97 | POLB (0.44) | TYMPPOLBPOLA1POLD1TK1 | |
| SCHEMBL4342113 | 0.87 | TYMP (0.49) | TYMPTK1MAPK1 | |
| SCHEMBL28575356 | 0.86 | TYMP (0.48) | TYMPTK1MAPK1 | |
| SCHEMBL446614 | 0.84 | POLA1 (0.35) | TYMPPOLBPOLA1POLD1 | |
| SCHEMBL447317 | 0.83 | POLB (0.38) | TYMPPOLBPOLA1POLD1TK1 | |
| SCHEMBL28563636 | 0.83 | POLB (0.38) | TYMPPOLBPOLA1POLD1TK1 | |
| SCHEMBL20541413 | 0.81 | TYMP (0.40) | TYMPPOLBPOLA1POLD1TK1 | |
| SCHEMBL6911384 | 0.80 | TYMP (0.44) | TYMPTK1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9066866-B2 | Direct cellular energy delivery system | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) | 2015-06-30 | — | — | US | claimed |
| CN-122029175-A | Modified nucleotide for improving chain offset, preparation method and application thereof | 深圳华大智造科技股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20260124229-A1 | COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF | FLAGSHIP PIONEERING INNOVATIONS VI LLC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260124228-A1 | COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF | FLAGSHIP PIONEERING INNOVATIONS VI LLC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260115219-A1 | COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF | FLAGSHIP PIONEERING INNOVATIONS VI LLC (US) | 2026-04-30 | — | — | US | disclosed |
| US-12539309-B2 | Compositions comprising circular polyribonucleotides and uses thereof | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2026-02-03 | — | — | US | disclosed |
| US-20250381211-A1 | COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF | FLAGSHIP PIONEERING INNOVATIONS VI, LLC | 2025-12-18 | — | — | US | disclosed |
| US-12480117-B2 | Compositions comprising modified circular polyribonucleotides and uses thereof | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2025-11-25 | — | — | US | disclosed |
| US-12357653-B2 | Compositions comprising circular polyribonucleotides and uses thereof | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2025-07-15 | — | — | US | disclosed |
| CN-119790161-A | Use of heteroaromatic compounds in nucleic acid detection | 深圳华大生命科学研究院 | 2025-04-08 | — | — | CN | disclosed |
| US-7807881-B2 | Methods to confer herbicide resistance | ATHENIX CORP. (US) | 2010-10-05 | — | — | US | disclosed |
| US-20090241219-A1 | GDC-2 GENES CONFERRING HERBICIDE RESISTANCE | ATHENIX CORPORATION (US) | 2009-09-24 | — | — | US | disclosed |
| US-20090148958-A1 | NUCLEOTIDE-TRANSITION METAL COMPLEX CATALYST | ONECELL INC. | 2009-06-11 | — | — | US | disclosed |
| US-7538262-B2 | GDC-2 genes conferring herbicide resistance | ATHENIX CORPORATION (US) | 2009-05-26 | — | — | US | disclosed |
| US-20070107078-A1 | Methods to confer herbicide resistance | ATHENIX CORPORATION (US) | 2007-05-10 | — | — | US | disclosed |
| US-20060021094-A1 | GDC-2 genes conferring herbicide resistance | ATHENIX CORPORATION (US) | 2006-01-26 | — | — | US | disclosed |
| EP-1601774-A2 | GDC-2 GENES CONFERRING HERBICIDE RESISTANCE | Athenix Corporation (US) | 2005-12-07 | — | — | EP | disclosed |
| US-20050204436-A1 | Using vector transformation to generate glyphosate resistant crop plants | ATHENIX CORPORATION (US) | 2005-09-15 | — | — | US | disclosed |
| WO-2005003362-A2 | METHODS TO CONFER HERBICIDE RESISTANCE | ATHENIX CORPORATION (US) | 2005-01-13 | — | — | WO | disclosed |
| WO-2004111245-A2 | GDC-2 GENES CONFERRING HERBICIDE RESISTANCE | ATHENIX CORPORATION (US) | 2004-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124229-A1 | COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF | RNGTT, RPL21, RPL17 | TYMP 208/4885POLB 225/4885POLA1 357/4885 |
| US-12539309-B2 | Compositions comprising circular polyribonucleotides and uses thereof | EIF4B, IGF2BP3, EIF4A3 | TYMP 3519/4885POLB 1549/4885POLA1 3898/4885 |
| US-20260115219-A1 | COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF | UPF1, CPSF6, RNGTT | TYMP 390/4885POLB 395/4885POLA1 633/4885 |
| US-20260124228-A1 | COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF | RNGTT, RPL30, EIF4A2 | TYMP 313/4885POLB 343/4885POLA1 449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.